- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Immunocore (IMCR)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 476.85 mm | 476.85 mm | 476.85 mm | 476.85 mm | 476.85 mm | 476.85 mm |
Cash burn (monthly) | (no burn) | 29.66 mm | (no burn) | 3.60 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | 76.78 mm | n/a | 9.33 mm | n/a | n/a |
Cash remaining | n/a | 400.06 mm | n/a | 467.51 mm | n/a | n/a |
Runway (months of cash) | n/a | 13.5 | n/a | 129.7 | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 116 |
Opened positions | 14 |
Closed positions | 27 |
Increased positions | 35 |
Reduced positions | 43 |
13F shares | Current |
---|---|
Total value | 1.06 tn |
Total shares | 47.51 mm |
Total puts | 38.70 k |
Total calls | 75.50 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
T. Rowe Price Investment Management | 6.70 mm | $197.66 mm |
Wellington Management | 6.62 mm | $195.20 bn |
RTW Investments | 4.87 mm | $143.66 bn |
FMR | 4.82 mm | $142.12 bn |
Primecap Management | 2.67 mm | $78.72 bn |
T. Rowe Price | 2.19 mm | $64.53 mm |
Malin Life Sciences | 2.11 mm | $111.40 mm |
Tang Capital Management | 1.56 mm | $45.89 bn |
Baker Bros. Advisors | 1.52 mm | $44.70 bn |
General Atlantic | 1.26 mm | $37.22 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 May 25 | Baker Bros. Advisors | Non-Qualified Share Option Ordinary Shares | Grant | Acquire A | Yes | No | 29.06 | 26,198 | 761.31 k | 26,198 |
15 May 25 | Baker Bros. Advisors | Non-Qualified Share Option Ordinary Shares | Grant | Acquire A | Yes | No | 29.06 | 26,198 | 761.31 k | 26,198 |
15 May 25 | Roy Steven Herbst | Share Option Ordinary Shares | Grant | Acquire A | No | No | 29.06 | 26,198 | 761.31 k | 26,198 |
15 May 25 | Kristine Peterson | Share Option Ordinary Shares | Grant | Acquire A | No | No | 29.06 | 26,198 | 761.31 k | 26,198 |
15 May 25 | Siddharth Kaul | Share Option Ordinary Shares | Grant | Acquire A | No | No | 29.06 | 26,198 | 761.31 k | 26,198 |
15 May 25 | John Irving Bell | Share Option Ordinary Shares | Grant | Acquire A | No | No | 29.06 | 26,198 | 761.31 k | 26,198 |